Literature DB >> 8136157

Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung.

W Mariencheck1, E Crouch.   

Abstract

The production of pulmonary surfactant protein D (SP-D) increases abruptly during late gestation, and the accumulation of this protein in lung tissue is increased following the exposure of fetal rats to glucocorticoids in utero. To examine the regulation of these events, we administered dexamethasone (Dex; 1 mg/kg/day intramuscularly for 3 days), or saline, to timed-pregnant rats and harvested the lungs on days 19 to 21 of gestation. Samples of pooled fetal lungs were analyzed for SP-D protein, mRNA, and gene transcription by immunoblot, Northern hybridization, and nuclear run-off transcription assays. Lungs from 19 day controls showed barely detectable levels of SP-D gene transcription and negligible accumulation of SP-D message. However, SP-D transcription and the accumulation of SP-D mRNA and protein were readily detected in lungs from 19 day Dex-treated rats. Dexamethasone also caused dose- and time-dependent increases in SP-D protein and mRNA accumulation in 19 day fetal lung explants. Immunohistochemistry of control 19 day lung using antibodies to rat SP-D showed only weak labeling of a small number of airway epithelial cells. By contrast, Dex-exposed rats showed strong staining of columnar and cuboidal epithelial cells lining airways and epithelial tubules and cuboidal cells lining primitive air sacs. In situ hybridization assays showed similar alterations in the number, intensity, and distribution of labeled epithelial cells in 19 day Dex-exposed lungs and demonstrated labeling of alveolar type II and nonciliated columnar cells in adult lung. These data indicate that the accelerated lung maturation accompanying glucocorticoid exposure in utero is associated with a precocious increase in SP-D gene transcription and protein production by pulmonary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136157     DOI: 10.1165/ajrcmb.10.4.8136157

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  Monocytic/macrophagic pneumonitis after intrabronchial deposition of vascular endothelial growth factor in neonatal lambs.

Authors:  D K Meyerholz; B Grubor; T Lazic; J M Gallup; M M A de Macedo; P B McCray; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

Review 2.  The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema.

Authors:  H Clark; K Reid
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

Review 3.  Surfactant protein-D and pulmonary host defense.

Authors:  E C Crouch
Journal:  Respir Res       Date:  2000-08-25

4.  Ozone Inhalation Attenuated the Effects of Budesonide on Aspergillus fumigatus-Induced Airway Inflammation and Hyperreactivity in Mice.

Authors:  Cameron H Flayer; Moyar Q Ge; Jin W Hwang; Blerina Kokalari; Imre G Redai; Zhilong Jiang; Angela Haczku
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

5.  Dexamethasone Treatment Increases the Intracellular Calcium Level Through TRPV6 in A549 Cells.

Authors:  Bo-Hui Jeon; Yeong-Min Yoo; Eui-Man Jung; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 6.  Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma.

Authors:  Chioma Enweasor; Cameron H Flayer; Angela Haczku
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

7.  Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study.

Authors:  Michael W Sims; Ruth M Tal-Singer; Sonja Kierstein; Ali I Musani; Michael F Beers; Reynold A Panettieri; Angela Haczku
Journal:  Respir Res       Date:  2008-01-28

Review 8.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.